Pharming Group N.V.
PHAR | NASDAQ
$12.23
+$0.10 (+0.82%)
At close: Oct 30, 2026, 4:00 PM ET
$12.67
+$0.44 (+3.60%)
Pre-market:
Nov 2, 2026, 8:47 AM ET
TTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 25.46M | 15.84M | 19.88M | 12.85M | 14.73M | 3.48M | -3.66M | -8.49M | -17.2M | -15.41M | -11.96M | -12.01M | -28.06M | -22.09M | -5.92M | 14.99M | 35.13M | 25.43M | 13.22M | 21.78M | 7.14M | 31.27M | 38.81M |
Depreciation & Amortization | 12.13M | 12.09M | 11.75M | 11.22M | 15.71M | 15.73M | 12.73M | 16.07M | 15.93M | 16.09M | 19.54M | 15.93M | 15.34M | 14.39M | 13.3M | 13.19M | 18.93M | 19.31M | 19.7M | 19.57M | 9.83M | 9.96M | 9.13M |
Stock-Based Compensation | 11.09M | 14.29M | 14.42M | 13.77M | 11.9M | 11.61M | 11.4M | 11.25M | 11.92M | 10.97M | 10.12M | 9.25M | 7.81M | 7.48M | 6.88M | 6.39M | 4.52M | 2.88M | 2.96M | 3.8M | 3.8M | 3.8M | 1.91M |
Other Working Capital | -913.85K | 5.29M | 23.02M | 15.03M | -3.97M | -2.55M | 3.72M | -2.79M | 11.88M | 8.51M | 7.72M | 16.01M | 20.26M | 14.99M | 12.84M | 12.27M | 441K | 2.52M | -1.93M | -4.59M | -678.46K | -6.66M | -2.58M |
Other Non-Cash Items | 9.16M | -2.88M | 970K | 6.49M | 7.01M | -64K | -6.78M | -10.55M | -5.82M | -1.13M | -14.06M | -13.51M | -7.36M | -9.94M | -8.03M | -11.72M | -22.23M | -21.26M | 1.54M | -4.73M | 33.05M | 33.52M | 29.36M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -25.31M | -7.34M | 9.41M | 10.39M | 3.99M | 290K | -7.61M | -10.07M | -4.37M | -16.28M | -5.8M | -16.96M | -11.36M | -4.4M | -7.17M | -387K | -3.66M | -3.08M | -8.79M | -5.34M | -6.99M | -16.32M | -2.54M |
Operating Cash Flow | 32.52M | 32M | 56.43M | 54.71M | 53.33M | 31.05M | 6.08M | -1.8M | 451K | -5.76M | -2.16M | -17.3M | -23.64M | -14.56M | -936K | 22.46M | 32.68M | 23.28M | 28.63M | 35.09M | 46.84M | 62.22M | 76.67M |
Capital Expenditures | -869.4K | -659.45K | -705K | -755K | -622K | -918K | -1M | -796K | -991K | -772K | -1.33M | -1.46M | -1.45M | -1.41M | -1.82M | -1.98M | -4.93M | -6.82M | -10.39M | -12.98M | -14.26M | -13.83M | -12.5M |
Cash Acquisitions | -8K | -310K | -328K | -58.22M | -58.21M | -57.91M | -57.89M | n/a | n/a | n/a | n/a | n/a | -84K | -278K | 7.3M | 7.3M | 7.38M | 7.58M | -385.68K | 12.32K | -341.91K | -327.29K | 36.05K |
Purchase of Investments | -102.32M | -102.38M | -102.65M | -2K | -62.07M | -171.86M | -189.54M | -284.31M | -372.36M | -407.12M | -389.45M | -294.67M | -144.55M | n/a | n/a | n/a | 5.22K | -4.57M | -4.57M | -4.57M | -4.57M | n/a | n/a |
Sales Maturities Of Investments | 18.3M | 18.33M | 35.48M | 85.23M | 137.4M | 251.89M | 291.04M | 318.7M | 412.65M | 384.59M | 328.33M | 232.81M | 86.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -451 | -451 | -1K | -1K | n/a | n/a | -1.97M | -1.97M | -1.8M | -1.77M | 21.28M | 21.28M | 21.1M | 21.08M | -1K | -1K | -1K | -1K | -1.33 | -1.33 | -1 | n/a | n/a |
Investing Cash Flow | -84.9M | -85.01M | -68.2M | 26.25M | 16.51M | 21.21M | 40.65M | 31.62M | 37.5M | -25.08M | -41.16M | -42.04M | -38.53M | 19.4M | 5.48M | 5.32M | -358.29K | -7.48M | -19M | -21.19M | -20.02M | -14.16M | -12.46M |
Debt Repayment | -15.26M | -16.36M | -16.51M | -4.25M | -4.39M | -4.49M | -34.31M | -34.63M | -34.39M | -34.21M | -4.58M | -4.86M | -4.5M | -4.29M | -3.82M | -3.31M | -2.39M | -1.59M | -1.87M | -1.61M | 4.29M | 7.91M | 9.31M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.07M | -5.31M | -7.95M | -14.07M | -14.01M | -12.03M | -6.71M | -1.9M | 1.14M | 7.65M | 3.7M | 3.12M | 2.91M | -5.28M | -3.87M | -3.95M | -4.71M | -3.58M | -28.1M | -28.5M | -30.77M | -33.77M | -9.99M |
Financial Cash Flow | -8.38M | 1.96M | -1.01M | 1.5M | -1.75M | -13.11M | -38.66M | -34.41M | -33.23M | -26.56M | -880K | -1.04M | 259K | -6.9M | -4.72M | -4.98M | -5.49M | -4.03M | -25.95M | -25.44M | -21.66M | -21.17M | 2.45M |
Net Cash Flow | 56.47M | 65.47M | -7.71M | 90.36M | 71.71M | 44.95M | 8.2M | -6.8M | 6.01M | -57.88M | -45.54M | -58.25M | -46.7M | 2.41M | -4.89M | 15.42M | 4.63M | 901K | -20.22M | -16.5M | -2.07M | 11.74M | 56.8M |
Free Cash Flow | 31.65M | 31.34M | 55.72M | 53.95M | 52.71M | 30.13M | 5.08M | -2.59M | -540K | -6.54M | -3.49M | -18.77M | -25.09M | -15.96M | -2.75M | 20.48M | 27.76M | 16.46M | 18.24M | 22.11M | 32.58M | 48.39M | 64.17M |
Adj. Free Cash Flow | 20.57M | 17.05M | 41.31M | 40.19M | 40.81M | 18.52M | -6.32M | -13.84M | -12.46M | -17.5M | -13.61M | -28.02M | -32.9M | -23.44M | -9.63M | 14.09M | 23.24M | 13.58M | 15.28M | 18.31M | 28.77M | 44.59M | 62.26M |
Maintenance CapEx | -869.4K | -589.45K | -507K | -269K | n/a | n/a | n/a | n/a | n/a | n/a | -178.79K | -393.79K | -708.79K | -708.79K | -1.66M | -1.45M | -4.4M | -6.4M | -9.49M | -12.46M | -12.13M | -10.46M | -9.65M |
Growth CapEx | n/a | -70K | -198K | -486K | -622K | -918K | -1M | -796K | -991K | -772K | -1.15M | -1.07M | -739.21K | -696.21K | -154.9K | -529.9K | -529.9K | -425.9K | -895.24K | -520.24K | -2.13M | -3.37M | -2.85M |
Owner Earnings | 31.65M | 31.41M | 55.92M | 54.44M | 53.33M | 31.05M | 6.08M | -1.8M | 451K | -5.76M | -2.34M | -17.7M | -24.35M | -15.26M | -2.6M | 21.01M | 28.29M | 16.88M | 19.14M | 22.63M | 34.71M | 51.76M | 67.01M |
Add to Watchlist
Select watchlists to add or remove PHAR